Circassia Group (LON:CIR) Trading 1.8% Higher

Circassia Group Plc (LON:CIRGet Rating)’s stock price traded up 1.8% on Tuesday . The company traded as high as GBX 32.50 ($0.40) and last traded at GBX 31.85 ($0.39). 3,785,218 shares traded hands during trading, an increase of 259% from the average session volume of 1,053,949 shares. The stock had previously closed at GBX 31.30 ($0.39).

The firm has a market cap of £133.55 million and a PE ratio of 35.39. The company has a quick ratio of 1.50, a current ratio of 1.83 and a debt-to-equity ratio of 1.95. The business has a fifty day moving average of GBX 36.50.

In other news, insider Jonathan Emms acquired 15,079 shares of the firm’s stock in a transaction that occurred on Tuesday, March 29th. The stock was purchased at an average price of GBX 36 ($0.44) per share, with a total value of £5,428.44 ($6,692.69).

Circassia Group Company Profile (LON:CIR)

Circassia Group Plc, a medical device company, focuses on the respiratory diagnostics and monitoring products in the United States, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It offers NIOX and NIOX VERO, a fractional exhaled nitric oxide measurement and monitoring products for use in asthma diagnosis and management.

Featured Stories

Receive News & Ratings for Circassia Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Circassia Group and related companies with MarketBeat.com's FREE daily email newsletter.